Front-line chemo-immunotherapy for treating epithelial ovarian cancer: Part I CA125 and anti-CA125

• Main Authors: Szu-Ting Yang (Author), Wen-Hsun Chang (Author), Fang-Wei Chou (Author), Hung-Hsien Liu (Author), Wen-Ling Lee (Author), Peng-Hui Wang (Author)
• Format: Book
• Published: Elsevier, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The current standard therapy of epithelial ovarian cancer (EOC) is the combination of surgery (primary cytoreductive surgery or interval cytoreductive surgery) and platinum-based chemotherapy (mainly using paclitaxel and carboplatin either by neoadjuvant chemotherapy and/or by postoperative adjuvant...